Gottschalk, N.; Kimmig, R.; Lang, S.; Singh, M.; Brandau, S.
Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity. Int. J. Mol. Sci. 2012, 13, 12000-12016.
https://doi.org/10.3390/ijms130912000
AMA Style
Gottschalk N, Kimmig R, Lang S, Singh M, Brandau S.
Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity. International Journal of Molecular Sciences. 2012; 13(9):12000-12016.
https://doi.org/10.3390/ijms130912000
Chicago/Turabian Style
Gottschalk, Nina, Rainer Kimmig, Stephan Lang, Mahavir Singh, and Sven Brandau.
2012. "Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity" International Journal of Molecular Sciences 13, no. 9: 12000-12016.
https://doi.org/10.3390/ijms130912000
APA Style
Gottschalk, N., Kimmig, R., Lang, S., Singh, M., & Brandau, S.
(2012). Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity. International Journal of Molecular Sciences, 13(9), 12000-12016.
https://doi.org/10.3390/ijms130912000